The new members of the Advisory Committee on Immunization Practices began their tenure Wednesday by shifting the posture of ...

PatientPoint’s Project Futurama featured discussions on staying relevant in a digital age dominated by virtual healthcare and ...

President Donald Trump’s One Big Beautiful Bill Act, sprawling legislation to extend his tax cuts and enact much of his ...

The long-term health care industry is facing a double whammy from President Donald Trump’s crackdown on immigrants and the ...

Nearly seven months after the fatal shooting of an insurance CEO in New York drew widespread attention to health insurers’ ...

Yet despite the increased efforts from various health brands to raise awareness around menopause, both HCPs and patients ...

In Cannes last week, creative leaders from Area 23, The Bloc, Eversana and MMC joined MM+M in the Palais basement to walk the ...

Millions of Americans who have waited decades for fast internet connections will keep waiting after the Trump administration ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

What Cannes taught us about health creativity in 2025. By registering you consent to the collection and use of your ...

Millions of people are expected to lose access to Medicaid and Affordable Care Act marketplace health insurance plans if federal lawmakers approve the One Big Beautiful Bill Act, President Donald ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.